RYZB Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Benzinga - Mentions: AZN BMY LLY FUSN

AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments

2 years ago - By: Seeking Alpha - Mentions: LLY NVS BMY PNT

Radiopharmaceutical market to reach ~$14B by 2032 (NYSE:LLY)

2 years ago - By: Bristol Myers Squibb - Mentions: BMY

Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer

2 years ago - By: Brodsky & Smith LLC - Mentions: CBAY GILD DOOR OC ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay Therapeutics, Inc. (Nasdaq – CBAY), Masonite International Corporation (NYSE – DOOR), ZeroFox Holdings, Inc. (Nasdaq – ZFOX), RayzeBio, Inc. (Nasdaq – RYZB)

2 years ago - By: Bristol Myers Squibb - Mentions: BMY

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period

2 years ago - By: Seeking Alpha - Mentions: BMY MRTX KRTX

Bristol Myers stock cut at Redburn Atlantic (NYSE:BMY)

2 years ago - By: Seeking Alpha - Mentions: BMY JPM MRTX KRTX

Bristol-Myers looking for smaller deals after 2023 shopping spree: report (NYSE:BMY)

2 years ago - By: Investor's Business Daily - Mentions: LLY ARWR XBI BMY ...

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024

2 years ago - By: Benzinga - Mentions: BA C GE K ...

Cramer Says This 'Inexpensive' Stock Is 'Doing Some Great Things With Aerospace'

2 years ago - By: Brodsky & Smith LLC - Mentions: GRCL DSKE KRTX BMY ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)

2 years ago - By: Seeking Alpha - Mentions: BMY BAC MRTX KRTX

Bristol-Myers Squibb stock cut to Neutral at BofA (NYSE:BMY)

2 years ago - By: Seeking Alpha - Mentions: BMY ABBV PFE IMGN ...

What's in store for biotech M&A and IPOs in 2024? (NYSE:BMY)

2 years ago - By: Kahn Swick & Foti, LLC

RAYZEBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB

2 years ago - By: Investor's Business Daily - Mentions: TSLA BMY LI NIO ...

Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review

2 years ago - By: Seeking Alpha - Mentions: RJF FUSN LLY BMY ...

Fusion Pharma stock gains as Raymond James upgrades on M&A

2 years ago - By: Brodsky & Smith LLC - Mentions: BMY GRCL DSKE KRTX ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)

2 years ago - By: Seeking Alpha - Mentions: INTC BMY KRTX

Biggest stock movers today: Intel, RayzeBio, Nio, Airbnb, Lionsgate and more (NASDAQ:INTC)

2 years ago - By: Seeking Alpha - Mentions: ATNM FUSN BMY

Actinium, Fusion stocks rally on $4.1B RayzeBio takeover deal (NYSE:ATNM)

2 years ago - By: Seeking Alpha - Mentions: RY RY.CA FUSN LLY ...

RAYZEBIO INC (RYZB) Stock News

RYZB Latest News, Press Relases and Analysis

AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments

Radiopharmaceutical market to reach ~$14B by 2032 (NYSE:LLY)

Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay Therapeutics, Inc. (Nasdaq – CBAY), Masonite International Corporation (NYSE – DOOR), ZeroFox Holdings, Inc. (Nasdaq – ZFOX), RayzeBio, Inc. (Nasdaq – RYZB)

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period

Bristol Myers stock cut at Redburn Atlantic (NYSE:BMY)

Bristol-Myers looking for smaller deals after 2023 shopping spree: report (NYSE:BMY)

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024

Cramer Says This 'Inexpensive' Stock Is 'Doing Some Great Things With Aerospace'

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)

Bristol-Myers Squibb stock cut to Neutral at BofA (NYSE:BMY)

What's in store for biotech M&A and IPOs in 2024? (NYSE:BMY)

RAYZEBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB

Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review

Fusion Pharma stock gains as Raymond James upgrades on M&A

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)

Biggest stock movers today: Intel, RayzeBio, Nio, Airbnb, Lionsgate and more (NASDAQ:INTC)

Actinium, Fusion stocks rally on $4.1B RayzeBio takeover deal (NYSE:ATNM)

RBC says Bristol Myers/RayzeBio deal validates Fusion 's approach (NASDAQ:FUSN)